{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:09:57Z","timestamp":1773515397212,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.iac.2023.01.001","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T08:27:07Z","timestamp":1677832027000},"page":"379-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody\u2013Associated Vasculitis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-4665","authenticated-orcid":false,"given":"Matthew","family":"Steward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3649-8253","authenticated-orcid":false,"given":"Hannah","family":"Thould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0758-5000","authenticated-orcid":false,"given":"Aye","family":"Myat Noe Khin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7099-1872","authenticated-orcid":false,"given":"Michael A.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.iac.2023.01.001_bib1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.202005-1628SO","article-title":"International Consensus on Antineutrophil Cytoplasmic Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis","volume":"202","author":"Moiseev","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2023.01.001_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0025-6196(12)62575-0","article-title":"Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients","volume":"65","author":"Nada","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.iac.2023.01.001_bib3","first-page":"46","article-title":"Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody","volume":"35","author":"Arimura","year":"1995","journal-title":"Ryumachi"},{"issue":"7","key":"10.1016\/j.iac.2023.01.001_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstitial lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.iac.2023.01.001_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00408-016-9851-x","article-title":"Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias","volume":"194","author":"Hozumi","year":"2016","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1183\/09031936.00110109","article-title":"Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis","volume":"36","author":"Tzelepis","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2023.01.001_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.rmed.2013.01.006","article-title":"Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangiitis in the course of idiopathic pulmonary fibrosis","volume":"107","author":"Ando","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2023.01.001_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.chest.2019.05.014","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis","volume":"156","author":"Liu","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.iac.2023.01.001_bib9","doi-asserted-by":"crossref","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","article-title":"Anti-neutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12890-021-01451-4","article-title":"Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iac.2023.01.001_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamainternmed.2020.0675","article-title":"Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"180","author":"McDermott","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.iac.2023.01.001_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.iac.2023.01.001_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/art.10830","article-title":"Are environmental factors important in primary systemic vasculitis? A case-control study","volume":"48","author":"Lane","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.iac.2023.01.001_bib15","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.iac.2023.01.001_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/14397595.2016.1140274","article-title":"Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study","volume":"26","author":"Sada","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.iac.2023.01.001_bib17","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.iac.2023.01.001_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","article-title":"Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden","volume":"46","author":"Mohammad","year":"2007","journal-title":"Rheumatology"},{"issue":"16","key":"10.1016\/j.iac.2023.01.001_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A\u00a0common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iac.2023.01.001_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","article-title":"Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis","volume":"68","author":"Stock","year":"2013","journal-title":"Thorax"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2023.01.001_bib21","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1513\/AnnalsATS.201503-110AW","article-title":"MUC5B and Idiopathic Pulmonary Fibrosis","volume":"12","author":"Yang","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.iac.2023.01.001_bib22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/annrheumdis-2018-214263","volume":"78","author":"Namba","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","article-title":"Antimyeloperoxidase-associated lung disease. An experimental model","volume":"160","author":"Foucher","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.iac.2023.01.001_bib24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1183\/09031936.00148409","article-title":"The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis","volume":"37","author":"Guilpain","year":"2011","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-06-290171","article-title":"Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity","volume":"117","author":"Metzler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.iac.2023.01.001_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular Mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.4359","article-title":"Neutrophil extracellular traps promote differentiation and function of fibroblasts","volume":"233","author":"Chrysanthopoulou","year":"2014","journal-title":"J\u00a0Pathol"},{"issue":"4","key":"10.1016\/j.iac.2023.01.001_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1165\/rcmb.2006-0012OC","article-title":"Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway","volume":"35","author":"Lee","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.iac.2023.01.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00001","article-title":"NET balancing: a problem in inflammatory lung diseases","volume":"4","author":"Cheng","year":"2013","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.iac.2023.01.001_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/thorax.55.6.502","article-title":"Rare diseases bullet 10: Small vessel vasculitis of the lung","volume":"55","author":"Schwarz","year":"2000","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.iac.2023.01.001_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-2004-836146","article-title":"Pulmonary capillaritis","volume":"25","author":"Lee","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.iac.2023.01.001_bib32","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1378\/chest.113.6.1609","article-title":"Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease","volume":"113","author":"Schwarz","year":"1998","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.iac.2023.01.001_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1055\/s-0038-1668533","article-title":"Alveolar Hemorrhage in Vasculitis (Primary and Secondary)","volume":"39","author":"Nasser","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/ajkd.2002.29876","article-title":"Pulmonary renal syndrome: a 4-year, single-center experience","volume":"39","author":"Gallagher","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.iac.2023.01.001_bib35","doi-asserted-by":"crossref","first-page":"106234","DOI":"10.1016\/j.rmed.2020.106234","article-title":"Idiopathic pulmonary hemosiderosis: A state of the art review","volume":"176","author":"Saha","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2023.01.001_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1309\/0B06Y93EGE6TQ36Y","article-title":"The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis","volume":"119","author":"Magro","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.iac.2023.01.001_bib37","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","article-title":"Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study","volume":"50","author":"Arulkumaran","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.iac.2023.01.001_bib38","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/01.rct.0000135280.79012.c7","article-title":"Thoracic manifestation of myeloperoxidase\/antineutrophil cytoplasmic antibody (MPO-ANCA)-related disease. CT findings in 51 patients","volume":"28","author":"Ando","year":"2004","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib39","doi-asserted-by":"crossref","first-page":"190321","DOI":"10.1183\/20734735.0321-2019","article-title":"Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients","volume":"16","author":"Suarez-Cuartin","year":"2020","journal-title":"Breathe"},{"key":"10.1016\/j.iac.2023.01.001_bib40","first-page":"195","article-title":"Radiologic and pathologic characteristics of myeloperoxidase-antineutrophil cytoplasmic antibody-associated interstitial lung disease: a retrospective analysis","volume":"36","author":"Baqir","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"8","key":"10.1016\/j.iac.2023.01.001_bib41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0000000000001357","article-title":"Interstitial Lung Disease in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients: Comparison With Idiopathic Pulmonary Fibrosis","volume":"27","author":"Kwon","year":"2021","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2466-14-8","article-title":"A\u00a0retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.iac.2023.01.001_bib43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.00216311","article-title":"Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis","volume":"40","author":"Tzouvelekis","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2023.01.001_bib44","first-page":"128","article-title":"Microscopic polyangiitis preceded by combined pulmonary fibrosis and emphysema","volume":"15","author":"Gocho","year":"2015","journal-title":"Respir Med Case Rep"},{"issue":"9","key":"10.1016\/j.iac.2023.01.001_bib45","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-019-0969-5","article-title":"Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study","volume":"19","author":"Watanabe","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib47","first-page":"37","article-title":"Interstitial lung disease and microscopic polyangiitis in Chilean patients","volume":"37","author":"Wurmann","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2214\/AJR.18.20967","article-title":"Chest High-Resolution CT Findings of Microscopic Polyangiitis: A Japanese First Nationwide Prospective Cohort Study","volume":"213","author":"Suzuki","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib49","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.39475","article-title":"Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients With Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital-Based Japanese Patients","volume":"68","author":"Yamagata","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.iac.2023.01.001_bib50","article-title":"Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features, and mortality","volume":"keac339","author":"Doliner","year":"2022","journal-title":"Rheumatology"},{"issue":"24","key":"10.1016\/j.iac.2023.01.001_bib51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","article-title":"Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature","volume":"93","author":"Comarmond","year":"2014","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.iac.2023.01.001_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/rcr2.123","article-title":"Organizing pneumonia associated with myeloperoxidase anti-neutrophil cytoplasmic antibody","volume":"3","author":"Imokawa","year":"2015","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.iac.2023.01.001_bib53","first-page":"101294","article-title":"Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with a unique imaging presentation of organizing pneumonia: A case report","volume":"31","author":"Takada","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.iac.2023.01.001_bib54","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Annals of the","volume":"75","author":"Yates","year":"2016","journal-title":"Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.iac.2023.01.001_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2008.096131","article-title":"Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature","volume":"68","author":"Hervier","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.iac.2023.01.001_bib56","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00296-021-04891-7","article-title":"Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients","volume":"41","author":"Yamaguchi","year":"2021","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.iac.2023.01.001_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12890-019-0880-0","article-title":"Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience","volume":"19","author":"Kawamura","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"21","key":"10.1016\/j.iac.2023.01.001_bib58","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iac.2023.01.001_bib59","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/MCP.0000000000000600","article-title":"New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?","volume":"25","author":"Morisset","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.iac.2023.01.001_bib60","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.iac.2023.01.001_bib61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.iac.2023.01.001_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.resinv.2022.03.004","article-title":"Current perspective of progressive-fibrosing interstitial lung disease","volume":"60","author":"Kishaba","year":"2022","journal-title":"Respir Investig"},{"key":"10.1016\/j.iac.2023.01.001_bib63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"13","key":"10.1016\/j.iac.2023.01.001_bib64","first-page":"3835","article-title":"Anti-Inflammatory and\/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review","volume":"11","author":"Yamakawa","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.iac.2023.01.001_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/1479973121994562","article-title":"Impact of interstitial lung disease on mortality in ANCA-associated vasculitis: A systematic literature review and meta-analysis","volume":"18","author":"Zhou","year":"2021","journal-title":"Chron Respir Dis"},{"issue":"6","key":"10.1016\/j.iac.2023.01.001_bib66","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.chest.2021.01.083","article-title":"Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis","volume":"159","author":"Hozumi","year":"2021","journal-title":"Chest"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856123000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:54:24Z","timestamp":1760180064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856123000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0889856123000012"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2023.01.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody\u2013Associated Vasculitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2023.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}